China Regenerative Medicine International Limited

Informe acción SEHK:8158

Capitalización de mercado: HK$95.8m

Salud financiera de hoja de balance de China Regenerative Medicine International

Salud financiera controles de criterios 4/6

China Regenerative Medicine International tiene un patrimonio de los accionistas total de HK$25.1M y una deuda total de HK$41.2M, lo que sitúa su ratio deuda-patrimonio en 164%. Sus activos y pasivos totales son HK$145.1M y HK$119.9M respectivamente.

Información clave

164.0%

Ratio deuda-patrimonio

HK$41.21m

Deuda

Ratio de cobertura de interesesn/a
EfectivoHK$1.85m
PatrimonioHK$25.14m
Total pasivoHK$119.94m
Activos totalesHK$145.07m

Actualizaciones recientes sobre salud financiera

Recent updates

Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

Mar 05
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

Jan 04
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

Sep 21
These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Jun 11
China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

May 22
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Apr 13
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Sep 22
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

Mar 16
Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Feb 08
What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Dec 15
Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Nov 25
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Nov 24
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (HK$132.9M) de 8158 superan a sus pasivos a corto plazo (HK$98.2M).

Pasivo a largo plazo: Los activos a corto plazo de 8158 (HK$132.9M) superan a sus pasivos a largo plazo (HK$21.7M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de 8158 (156.6%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de 8158 ha crecido de 46% a 164% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable 8158 tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: 8158 no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 25.7% al año.


Descubre empresas con salud financiera